Article Versions Notes

Kaloudi A, Lymperis E, Giarika A, Dalm S, Orlandi F, Barbato D, Tedesco M, Maina T, De Jong M, Nock BA. NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [⁶⁷Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice. Molecules. 2017; 22(11):1950. https://doi.org/10.3390/molecules22111950

Kaloudi, Aikaterini, Emmanouil Lymperis, Athina Giarika, Simone Dalm, Francesca Orlandi, Donato Barbato, Mattia Tedesco, Theodosia Maina, Marion De Jong, and Berthold A. Nock. 2017. "NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [⁶⁷Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice" Molecules 22, no. 11: 1950. https://doi.org/10.3390/molecules22111950

Kaloudi, A., Lymperis, E., Giarika, A., Dalm, S., Orlandi, F., Barbato, D., Tedesco, M., Maina, T., De Jong, M., & Nock, B. A. (2017). NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [⁶⁷Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice. Molecules, 22(11), 1950. https://doi.org/10.3390/molecules22111950